Recursion Pharmaceuticals... (RXRX)
6.49
0.17 (2.69%)
At close: Jan 15, 2025, 1:44 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -6.25 | -5.65 | -16.38 | -33.96 | -47.73 |
| PS Ratio | 45.98 | 34.11 | 291.68 | 874.38 | 1.74K |
| PB Ratio | 4.42 | 2.79 | 5.37 | -14.47 | -24.02 |
| P/FCF Ratio | -6.82 | -11.2 | -14.7 | -57.24 | -48.96 |
| P/OCF Ratio | -7.12 | -16.2 | -18.39 | -65.73 | -52.32 |
| OCF/S Ratio | -6.46 | -2.1 | -15.86 | -13.3 | -33.34 |
| Debt / Equity Ratio | 0.11 | 0.10 | 0.02 | -0.08 | -0.13 |
| Quick Ratio | 4.70 | 5.67 | 11.43 | 11.45 | 10.64 |
| Current Ratio | 4.70 | 5.68 | 11.46 | 11.67 | 11.43 |
| Asset Turnover | 0.07 | 0.06 | 0.02 | 0.01 | 0.02 |
| Interest Coverage | -3.61K | -4.47K | -61.92 | -62.22 | -98.33 |
| Return on Equity (ROE) | -0.71 | -0.49 | -0.33 | 0.43 | 0.50 |
| Return on Assets (ROA) | -0.5 | -0.34 | -0.29 | -0.29 | -0.62 |
| Return on Capital (ROIC) | -0.62 | -0.41 | -0.32 | -0.31 | -0.66 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 4.46% | -21.66% | 8.96% | -1.76K% | -2.58K% |
| Net Profit Margin | -735.99% | -603.36% | -1.78K% | -2.57K% | -3.65K% |
| Pretax Profit Margin | -745.1% | -603.5% | -1.86K% | -2.55K% | -3.62K% |
| Operating Profit Margin | -785.33% | -619.26% | -1.83K% | -2.48K% | -3.65K% |
| FCF Margin | -673.77% | -304.64% | -1.98K% | -1.53K% | -3.56K% |
| EBITDA Margin | -672.05% | -573.74% | -1.74K% | -2.39K% | -3.41K% |